Explore Business Standard
The government has launched a nationwide campaign 'Your Money, Your Right' to facilitate the settlement of unclaimed financial assets, and Rs 2,000 crore have been claimed by their rightful owners in October and November this year. The government launched the campaign on October 4 to facilitate the settlement of unclaimed financial assets, including bank deposits, insurance, dividends, shares, mutual funds and pensions, to their legitimate claimants. From October to December 5, 2025, camps have been held in 477 districts with participation of public representatives, district administration, and officials from financial institutions, Minister of State for Finance Pankaj Chaudhary said in a written reply to the Rajya Sabha. To maximise outreach during the campaign, standard operating procedures (SOPs), frequently asked questions (FAQs), and awareness material in major regional languages, along with short video messages, have been widely disseminated. District-level camps are organised
Morgan Stanley and Nippon India Mutual Fund (MF) are among the investors that bought around 63 lakh shares worth Rs 438 crore of HealthCare Global Enterprises (HCG) from private equity firm CVC Capital Partners through open market transactions, according to the NSE data. Motilal Oswal MF and Plutus Wealth Management are the other two entities that bought shares in HCG. On Wednesday, Morgan Stanley, Nippon India Mutual Fund (MF), Motilal Oswal MF and Plutus Wealth Management purchased 63 lakh equity shares representing a 4.52 per cent stake in Bengaluru-headquartered HCG. The transaction was valued at around Rs 437.85 crore, and was executed at an average price of Rs 695 apiece on the National Stock Exchange (NSE). Meanwhile, Luxembourg-based CVC Capital Partners through its affiliate, Aceso Company Pte Ltd offloaded these shares at the same price. After the stake sale, Aceso Company holding in HCG has come down to 4.24 per cent from 8.76 per cent. Shares of Healthcare Global ...
Medical device maker Poly Medicure Ltd on Wednesday said it will acquire 90 per cent stake in the Netherlands-based PendraCare Group from Wellinq Holdings B.V. at an enterprise value of Rs 188.5 crore (18.3 million euros). The company has signed definitive agreements to acquire the stake in PendraCare Group consisting of PendraCare Holdings and Wellinq Medical from Wellinq Holdings BV, Poly Medicure said in a statement. The balance 10 per cent stake will be acquired in 2030 on the basis of actual EBITDA for calendar year 2029, it added. The existing management of PendraCare will continue to lead the business and Sander Hartman, who will continue to hold 10 per cent non-voting shares in the group, will remain as the CEO. PendraCare Group develops, manufactures and sells innovative cardiology catheter solutions and provides design, development and manufacturing services to other global OEMs. "This move brings us a valuable, 'made-in-Europe' cardiology consumables business with FDA a